Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18542,897,1.02 [0.90-1.16],0.759611021438361
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17810,292,1.12 [0.91-1.39],0.2854816243348376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21010,174,0.93 [0.70-1.24],0.6357615529300511
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13037,1068,1.06 [0.94-1.20],0.3212262264712917
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,20963,127,0.99 [0.71-1.37],0.9374176831015107
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18573,95,1.45 [1.03-2.05],0.0336250243936126
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22395,126,0.99 [0.71-1.37],0.9492452608888946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22381,83,0.84 [0.56-1.28],0.4232670333612462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18094,70,1.27 [0.84-1.91],0.2576435677398978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21272,131,1.20 [0.89-1.63],0.2336686630476407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21227,86,1.27 [0.87-1.83],0.2136836192348713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22498,66,1.24 [0.81-1.89],0.3137823211028685
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22527,65,0.80 [0.50-1.28],0.3506784510082245
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22524,62,0.87 [0.54-1.40],0.556358041382046
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,22042,60,1.07 [0.67-1.70],0.7786892382055113
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",20949,432,1.08 [0.91-1.29],0.3707547352908573
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,20653,136,1.35 [1.02-1.81],0.0387537234962296
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,20829,312,0.97 [0.79-1.20],0.8023083787509382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16218,100,0.93 [0.64-1.36],0.7266850321338247
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16182,64,0.90 [0.56-1.44],0.6557346740611977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16504,386,0.92 [0.76-1.12],0.3996390577575928
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16516,398,0.92 [0.76-1.11],0.3820114416413566
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9260,374,1.07 [0.89-1.29],0.4654055673305054
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7437,205,0.83 [0.63-1.10],0.1918587383820128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16172,54,1.23 [0.76-1.99],0.4100282319872059
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19240,751,1.21 [1.06-1.38],0.0050741463642923
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21035,458,0.91 [0.76-1.08],0.2712977426983153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22005,152,0.93 [0.69-1.26],0.638965103407896
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22581,148,0.97 [0.71-1.31],0.8223263423079388
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,22269,82,0.94 [0.62-1.41],0.7559151315503696
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22586,92,1.30 [0.91-1.85],0.1501429280249728
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Stomach,22639,67,1.28 [0.84-1.93],0.2501488096685343
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,22404,289,0.91 [0.73-1.13],0.3892130218509706
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22620,99,0.91 [0.62-1.32],0.6034444405589616
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22624,84,0.69 [0.45-1.05],0.0826797552503273
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22542,58,0.76 [0.46-1.27],0.2982435789153066
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",22544,57,0.83 [0.50-1.37],0.4689474759967882
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,22482,142,1.09 [0.81-1.47],0.5873825263276568
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,22616,59,1.07 [0.67-1.70],0.7786410633379391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,22505,175,0.94 [0.71-1.24],0.6631043817108383
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of breast,11803,44,0.59 [0.32-1.06],0.0788786553047253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,11666,300,0.79 [0.64-0.99],0.0403398061506475
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21091,188,1.10 [0.85-1.43],0.4682324116745958
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20570,348,1.22 [1.01-1.48],0.0362032638054902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20570,348,1.22 [1.01-1.48],0.0362032638054902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18059,554,1.08 [0.92-1.26],0.3554686174575282
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22044,57,0.71 [0.43-1.19],0.1993883218998124
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22304,62,1.36 [0.89-2.08],0.1506675288206921
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16358,1626,1.08 [0.98-1.19],0.1052999628716261
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,20941,629,1.12 [0.97-1.30],0.1126224775803062
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,19902,156,1.17 [0.88-1.56],0.272411682406222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21073,163,0.94 [0.70-1.26],0.6611988220090625
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19889,143,1.11 [0.82-1.49],0.515331860885842
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,20506,760,1.10 [0.96-1.27],0.1623533720350343
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,20481,735,1.10 [0.96-1.27],0.170645488963278
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20797,183,0.98 [0.72-1.33],0.8845151950557617
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20797,183,0.98 [0.72-1.33],0.8845151950557617
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16176,1444,1.08 [0.97-1.19],0.1461266582079792
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14922,190,1.02 [0.78-1.33],0.9080913335398738
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16065,1333,1.09 [0.98-1.21],0.1236713158438554
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14789,57,1.32 [0.84-2.08],0.229220191777381
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14823,91,1.37 [0.96-1.96],0.0874094096817403
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,18525,527,1.16 [0.99-1.36],0.0731329910746105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18156,158,1.14 [0.84-1.53],0.3984427450736809
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22287,111,1.04 [0.73-1.49],0.8119258950615691
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22344,83,1.08 [0.72-1.63],0.7045045546712501
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21123,33,1.08 [0.57-2.03],0.814396772735861
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",22566,33,1.06 [0.56-2.01],0.8536504953564391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18031,33,1.08 [0.57-2.02],0.816002995611671
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Alcohol dependence,21131,41,0.87 [0.48-1.60],0.656793952603566
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,21053,49,1.32 [0.80-2.17],0.2780032674782969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18033,35,1.08 [0.58-2.01],0.8025007270602253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18254,256,1.26 [1.01-1.57],0.0380281028102137
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression,21216,227,1.21 [0.95-1.52],0.1183184233595048
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression or dysthymia,17899,195,1.26 [0.98-1.62],0.0657308664773302
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18101,103,0.96 [0.66-1.38],0.8131593403740207
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Other anxiety disorders,21268,60,1.08 [0.68-1.73],0.7313383574699788
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,18388,1458,1.06 [0.96-1.17],0.2217940255107079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16085,100,1.10 [0.76-1.57],0.6200450599987035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22550,77,1.03 [0.68-1.55],0.8903654815507919
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21341,458,1.06 [0.90-1.26],0.4764824738810505
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,21010,127,1.07 [0.77-1.47],0.695886644452069
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,20938,55,0.96 [0.58-1.59],0.8814204632322193
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22414,50,0.92 [0.54-1.56],0.7613991248055386
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21488,116,1.04 [0.74-1.45],0.8277784198890579
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,21042,159,1.20 [0.90-1.59],0.211553138912367
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,22114,118,1.15 [0.82-1.60],0.4225554193900819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21470,703,1.09 [0.95-1.25],0.2106119419716877
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",20868,101,1.02 [0.71-1.47],0.917844696905328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21195,428,1.12 [0.94-1.33],0.1973210436691813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22260,77,0.85 [0.55-1.30],0.4508522230749829
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,22241,58,0.83 [0.50-1.36],0.4525431064674284
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,22092,112,1.08 [0.77-1.51],0.675589447310662
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",21797,409,0.91 [0.76-1.10],0.3309191068548075
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21636,248,0.94 [0.74-1.19],0.5817914890121634
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21448,60,0.67 [0.40-1.11],0.1232499809337774
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21519,131,0.98 [0.71-1.36],0.9237079504649772
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21489,101,1.19 [0.84-1.68],0.3360569575525339
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17333,249,1.10 [0.88-1.39],0.3931006508750696
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17679,595,1.08 [0.93-1.25],0.3403991666457245
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21255,296,1.30 [1.07-1.59],0.0095212862231091
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22225,80,1.40 [0.96-2.04],0.0779883142799624
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2544,80,1.31 [0.88-1.95],0.1909598111481399
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",19761,80,1.43 [0.98-2.08],0.060970733119197
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,21674,134,0.89 [0.64-1.23],0.4723805499365605
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,21612,72,1.09 [0.72-1.66],0.684204765786651
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",21736,77,1.43 [0.99-2.07],0.0581199763583823
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,21975,97,0.72 [0.48-1.06],0.0978226563772977
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,22552,139,1.22 [0.91-1.63],0.1904948826830629
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,21447,112,1.23 [0.89-1.70],0.2071828380680337
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,13961,4490,1.00 [0.93-1.08],0.9194576316460346
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,21707,94,1.01 [0.69-1.46],0.9730330017679688
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14780,3149,1.05 [0.97-1.13],0.2355478539251024
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,14822,3191,1.05 [0.97-1.13],0.2031645211637949
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11739,108,1.31 [0.93-1.83],0.1213214491442057
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",19810,1795,1.00 [0.91-1.09],0.9265230344651454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,19084,1069,0.97 [0.87-1.10],0.6683060799556599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21279,338,1.03 [0.84-1.26],0.7743009198984154
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,21622,681,1.01 [0.88-1.17],0.8589565142446105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22482,128,0.97 [0.70-1.35],0.8656942145807325
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18438,423,0.99 [0.83-1.18],0.9011258325000582
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19448,1456,1.00 [0.91-1.11],0.9666124165891048
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,21524,135,1.42 [1.07-1.90],0.0157645272548959
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,21737,277,1.25 [1.01-1.54],0.0359130894671756
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21505,116,0.82 [0.58-1.17],0.2825042310787962
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21506,117,0.83 [0.58-1.18],0.2965884754823822
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11743,112,0.86 [0.60-1.23],0.3988909794958573
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16624,71,1.82 [1.27-2.61],0.0011942551617186
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,16725,172,0.75 [0.56-1.01],0.0612886831783423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8831,139,0.64 [0.45-0.90],0.0096383511383611
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9365,673,0.84 [0.72-0.98],0.0283401709840558
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,16646,93,0.80 [0.54-1.19],0.2679614280043426
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16672,119,0.64 [0.44-0.92],0.0147979131557944
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21030,288,1.03 [0.83-1.27],0.8172079073088134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",21383,196,1.28 [1.00-1.63],0.0492663282143992
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",21417,176,1.29 [0.99-1.67],0.0553464905887527
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",21528,156,1.38 [1.05-1.80],0.019207583370875
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21045,103,0.86 [0.60-1.25],0.4316230262926788
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21110,168,0.94 [0.70-1.25],0.6613900748634249
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),20960,164,1.14 [0.87-1.51],0.3443889309881452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,20939,143,1.18 [0.88-1.59],0.2720935427304548
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22362,137,1.24 [0.92-1.67],0.1572435661830328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,21297,501,0.89 [0.75-1.06],0.1921383319927635
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,20990,118,0.88 [0.62-1.24],0.4567728229230091
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,16682,2110,1.09 [1.00-1.19],0.0432407367814052
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22486,76,1.07 [0.71-1.61],0.7525434430923883
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20138,256,1.01 [0.80-1.27],0.9521341543786224
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20109,227,1.00 [0.78-1.28],0.999645167519049
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,21401,285,1.11 [0.90-1.38],0.3398878497844808
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,21392,276,1.11 [0.90-1.39],0.3323508977280974
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,21925,545,0.95 [0.81-1.11],0.5252501155385316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,21472,92,0.72 [0.48-1.08],0.1121550246051813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,21519,139,1.08 [0.80-1.47],0.6087360542093787
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21728,348,0.93 [0.76-1.13],0.4544673616038244
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,21513,133,0.76 [0.55-1.06],0.1107355121912977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7184,75,1.07 [0.70-1.63],0.7572453141438817
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19611,1103,1.19 [1.07-1.33],0.0016250730122162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,21018,238,1.17 [0.92-1.47],0.1926196174468647
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21068,288,1.15 [0.93-1.42],0.2089118936417519
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21068,288,1.15 [0.93-1.42],0.2089118936417519
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",20992,841,1.21 [1.07-1.37],0.0024799092803031
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Asthma,14712,841,1.25 [1.10-1.41],0.0006148554584074
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14329,841,1.25 [1.10-1.41],0.0006715505399525
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14703,832,1.23 [1.09-1.40],0.0011347714795043
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22090,121,1.19 [0.87-1.64],0.2813257072693892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,21056,93,1.38 [0.98-1.95],0.0645341808590109
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22184,93,1.39 [0.98-1.96],0.0622956904277424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21049,86,1.31 [0.91-1.88],0.1484132174448837
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,19891,142,0.89 [0.65-1.22],0.474472866362131
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,20036,287,0.89 [0.71-1.11],0.3062556430372554
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20983,128,0.89 [0.64-1.23],0.4719180174758449
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14620,6307,1.02 [0.96-1.09],0.5282758787392385
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22203,323,1.00 [0.82-1.23],0.998488392114642
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22637,40,0.83 [0.45-1.50],0.5315229049549737
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,22639,36,0.94 [0.51-1.74],0.8457335043616698
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,21969,89,1.21 [0.84-1.75],0.3086273630900913
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,21969,89,0.96 [0.65-1.42],0.8403162184638042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22634,44,0.77 [0.43-1.37],0.3742430212579239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,21974,94,0.81 [0.55-1.21],0.3072646116426897
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21707,89,1.31 [0.92-1.87],0.1292646462654087
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22530,58,1.25 [0.80-1.94],0.3354266553442635
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15996,337,1.03 [0.84-1.25],0.794812269705942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18173,2514,0.95 [0.88-1.03],0.191469156535091
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,16057,398,1.03 [0.86-1.24],0.7364026819707228
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16468,809,0.94 [0.83-1.08],0.3919498640515177
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15743,84,0.91 [0.60-1.36],0.6313206948405456
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15929,270,1.00 [0.80-1.24],0.9656195575255284
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15742,83,0.90 [0.59-1.35],0.6010404146038164
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,15859,200,0.81 [0.62-1.06],0.1270821183439965
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,15802,143,1.49 [1.14-1.95],0.0031241858767454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22465,98,1.66 [1.22-2.26],0.001391541435345
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,15802,143,0.78 [0.57-1.08],0.1307055335317977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16623,964,0.87 [0.76-0.98],0.0254676130200663
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,22507,87,0.98 [0.66-1.45],0.924865277038438
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,16138,479,0.92 [0.77-1.09],0.3150112248356156
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15877,218,0.75 [0.58-0.98],0.0345918579566903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22509,120,0.89 [0.63-1.26],0.5071056511194019
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,22496,76,0.96 [0.63-1.47],0.864612242251407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,19096,2014,1.03 [0.95-1.13],0.4395767161103727
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,17853,771,1.03 [0.90-1.17],0.7033239059698213
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,17211,129,1.11 [0.81-1.53],0.5040607447960317
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,17189,107,1.14 [0.81-1.60],0.4644585201084338
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18179,1097,1.03 [0.92-1.15],0.622019904468281
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21594,744,0.91 [0.80-1.05],0.2091834243700168
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,16566,2278,0.99 [0.91-1.08],0.8434791846153162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22294,43,0.92 [0.52-1.61],0.7589727184392554
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",22577,57,0.73 [0.44-1.22],0.2288526059215007
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,20907,57,0.73 [0.44-1.22],0.2305993152811144
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,20892,42,0.53 [0.28-0.99],0.0447739894682379
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",22500,141,0.83 [0.60-1.14],0.2402871665661667
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,20991,141,0.83 [0.60-1.14],0.2549784277636898
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",20981,131,0.84 [0.60-1.17],0.3067342149524751
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21465,615,0.94 [0.81-1.10],0.4542947933230147
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21456,606,0.94 [0.80-1.09],0.4007368284099171
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14409,121,1.11 [0.80-1.53],0.5419624758685331
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal stricture,22055,121,1.11 [0.81-1.53],0.516746405418963
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14366,78,1.16 [0.78-1.72],0.4732701689829951
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15171,883,0.99 [0.87-1.13],0.8757735863282369
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14438,150,0.85 [0.62-1.16],0.3113633701164578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14602,314,1.02 [0.83-1.26],0.8175044220970171
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,20574,281,1.01 [0.81-1.26],0.9053365396995262
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22164,93,1.11 [0.77-1.61],0.5752819986102868
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14393,105,0.95 [0.66-1.37],0.7926363097518885
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14338,50,1.36 [0.84-2.19],0.2079625298042734
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15244,956,1.01 [0.89-1.14],0.8901756663145084
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,14640,352,0.87 [0.71-1.07],0.1888407841631127
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22148,77,1.14 [0.76-1.71],0.5194142853260276
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,21771,123,0.84 [0.60-1.19],0.334354197457036
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,21719,71,0.96 [0.62-1.50],0.8705006942194294
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21188,711,1.10 [0.96-1.26],0.1865704589886966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,21060,583,1.10 [0.94-1.27],0.2292354809050217
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,20593,116,1.39 [1.02-1.89],0.0383224052366847
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20534,57,1.67 [1.13-2.47],0.0104011742363675
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,20546,69,1.18 [0.78-1.80],0.4352877145930316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),22459,69,1.17 [0.77-1.78],0.4690088463167009
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21160,329,1.01 [0.83-1.24],0.8949095885913493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,20901,70,1.21 [0.80-1.82],0.3693937049910279
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,20891,60,1.27 [0.82-1.96],0.288364579651781
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",20886,55,0.87 [0.52-1.45],0.5967764298813591
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21040,209,0.98 [0.76-1.27],0.9008078279212453
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,21031,200,0.96 [0.74-1.25],0.76174708279423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19006,1580,0.95 [0.86-1.04],0.2544464430262306
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22114,104,0.89 [0.61-1.28],0.5266810382998389
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22236,432,0.96 [0.80-1.15],0.647042988567003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20594,609,1.02 [0.88-1.19],0.7733953092165253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,21617,386,0.85 [0.70-1.03],0.0994847809788896
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21302,71,0.72 [0.45-1.14],0.1553454493426177
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,21507,276,0.89 [0.71-1.12],0.3339335365434215
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22334,91,0.84 [0.56-1.25],0.3855616247076738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22309,66,0.96 [0.61-1.51],0.8506166267102971
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22296,53,0.94 [0.56-1.57],0.8120559644955585
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22214,76,0.94 [0.61-1.43],0.7664976979220703
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22212,74,0.95 [0.62-1.46],0.8072686708222356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21854,50,1.00 [0.60-1.67],0.9972264016797904
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22163,359,0.96 [0.79-1.16],0.6580291891767751
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20097,112,0.71 [0.49-1.03],0.0687129567748712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20086,101,0.82 [0.56-1.19],0.2965828747890408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20054,69,0.91 [0.58-1.42],0.6674554050582785
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20208,223,1.22 [0.97-1.54],0.0958022962171819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20189,204,1.20 [0.94-1.53],0.146168182704638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14790,4326,1.03 [0.97-1.10],0.3530595385008528
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16353,2688,1.05 [0.97-1.14],0.1963695047373878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20062,1279,1.05 [0.95-1.17],0.3487200342465326
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,13847,182,1.24 [0.96-1.60],0.0972835845400436
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14235,570,1.10 [0.95-1.29],0.2019212561835749
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22130,176,1.30 [1.01-1.68],0.0433951063542184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22134,160,1.41 [1.09-1.83],0.0099257572836301
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15268,1603,1.05 [0.95-1.16],0.331076975296651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17742,1603,1.04 [0.94-1.14],0.4405593032555053
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,13755,90,0.90 [0.61-1.34],0.6130883381072578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",21887,87,0.89 [0.59-1.33],0.5637997542331662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13944,279,1.08 [0.88-1.34],0.459068396407098
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,13780,115,0.83 [0.58-1.18],0.2878341311999871
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14093,428,1.09 [0.92-1.30],0.3359034919778135
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22419,211,1.23 [0.97-1.57],0.0825777569308372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14377,712,1.08 [0.94-1.25],0.261397785488256
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14223,558,0.96 [0.81-1.12],0.5803418142262446
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,14958,1293,1.02 [0.92-1.13],0.7348426584054428
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13757,92,1.01 [0.69-1.47],0.9764400535667516
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13957,292,0.99 [0.80-1.22],0.9088848571246458
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13739,74,0.85 [0.55-1.32],0.4669759909089134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13755,90,1.24 [0.87-1.77],0.2324591048287322
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14088,423,1.10 [0.92-1.31],0.2977973004211506
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14047,382,1.12 [0.93-1.35],0.2304675132257665
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17023,271,0.96 [0.76-1.20],0.6931112806789206
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,21935,100,0.96 [0.66-1.39],0.8260238896623345
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,21905,70,1.34 [0.90-1.99],0.1488350742642017
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18722,77,1.22 [0.82-1.81],0.3257401986674035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19004,359,0.97 [0.79-1.18],0.7405815116949437
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19571,926,0.96 [0.85-1.09],0.566717752231628
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18877,232,0.93 [0.73-1.19],0.5775040417995361
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18756,111,1.08 [0.76-1.52],0.6772580369079582
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19331,686,0.98 [0.85-1.13],0.7712946790684554
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18687,42,1.06 [0.60-1.84],0.84942387399614
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18857,212,0.93 [0.72-1.20],0.5877850679387042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18729,84,0.86 [0.57-1.30],0.4831487682332287
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18731,86,0.66 [0.43-1.01],0.0575837027723841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18773,128,1.07 [0.77-1.47],0.6924057514772801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18705,60,1.01 [0.63-1.63],0.9534165008693464
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18929,284,0.96 [0.77-1.20],0.7041503482102447
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19113,330,1.14 [0.94-1.39],0.1805445331708925
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,18863,80,1.17 [0.79-1.73],0.4368745897740794
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,18900,117,0.97 [0.69-1.36],0.8517979188566698
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18870,87,1.37 [0.96-1.95],0.0790605911287649
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",18823,40,1.22 [0.71-2.12],0.4737162462792382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,18945,162,0.98 [0.73-1.31],0.8872981051599776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],18934,151,0.93 [0.69-1.25],0.6251578541481613
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19076,293,1.17 [0.95-1.44],0.1302790612239858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18839,56,0.83 [0.50-1.39],0.4850388316897736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,18883,100,0.96 [0.66-1.39],0.8396756288597621
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,18922,139,1.19 [0.89-1.61],0.2427044226153042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18831,48,0.74 [0.42-1.29],0.2917052568742933
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19235,452,0.92 [0.77-1.10],0.3393428905940552
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,18973,190,1.08 [0.83-1.40],0.5846213810169716
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19033,250,0.82 [0.64-1.04],0.10210489583959
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20282,238,1.02 [0.80-1.29],0.8956065448422016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20474,430,1.02 [0.86-1.22],0.7917864758679677
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20085,41,1.14 [0.66-1.98],0.6298517247228304
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20091,47,0.98 [0.58-1.68],0.9460880493099824
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20131,87,0.92 [0.62-1.38],0.7011232995829775
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16513,4007,0.96 [0.89-1.02],0.1984911177584422
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8748,850,1.02 [0.89-1.16],0.7822164606133256
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,18991,292,1.25 [1.02-1.54],0.0314413632866427
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18780,81,1.08 [0.72-1.62],0.7016421187304831
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19038,64,1.72 [1.19-2.49],0.0042103444707503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19063,89,1.06 [0.72-1.57],0.7662879272543395
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19053,79,1.18 [0.79-1.77],0.4163458077678758
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22287,248,0.96 [0.76-1.22],0.7399573891969653
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22044,89,1.45 [1.03-2.04],0.0349179030210356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22225,186,0.98 [0.74-1.28],0.8580173408250356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22113,74,0.87 [0.56-1.35],0.53589443208931
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19771,1175,1.07 [0.96-1.19],0.2308336757105471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,18702,106,0.91 [0.63-1.31],0.6164636089218585
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18690,94,1.29 [0.91-1.84],0.1531270808989079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18954,358,1.10 [0.91-1.33],0.338159380658253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18732,136,0.89 [0.65-1.23],0.4938322807622889
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19313,717,1.05 [0.92-1.21],0.456613232607134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8382,484,1.07 [0.90-1.27],0.4420600233897885
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),7966,68,1.15 [0.75-1.78],0.5228251083063813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,7959,61,1.13 [0.71-1.79],0.616427971665539
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",7969,71,1.09 [0.70-1.68],0.7117626205808938
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,7992,94,1.08 [0.74-1.58],0.6921781368327706
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8010,112,0.72 [0.49-1.05],0.0856564305467939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11692,227,0.68 [0.52-0.88],0.0033670679725606
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11541,76,0.61 [0.39-0.96],0.0333771629168137
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11544,79,0.76 [0.49-1.16],0.2040516337530564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11523,58,0.75 [0.45-1.24],0.2577216559041426
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11670,161,1.01 [0.76-1.34],0.9587358077349892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11558,49,0.78 [0.46-1.34],0.3688973030661492
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11562,53,1.04 [0.64-1.69],0.888247408881972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10809,1775,0.90 [0.81-0.98],0.0230804583402808
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,9097,63,1.17 [0.76-1.82],0.4774601646855644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9085,51,1.22 [0.75-1.97],0.423383102954816
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9511,477,1.03 [0.87-1.22],0.7222524802391944
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9139,105,1.01 [0.71-1.45],0.9446383335855372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9504,470,0.83 [0.70-0.99],0.0437848253562557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9182,148,0.53 [0.38-0.74],0.0002004172842289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9253,219,0.89 [0.69-1.14],0.3471899111482084
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9051,17,0.98 [0.41-2.36],0.9611614345529044
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9080,46,0.62 [0.34-1.11],0.1087541418786255
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",11815,62,0.58 [0.35-0.96],0.0349256347313989
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,11817,57,0.62 [0.37-1.05],0.0782770184316244
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,11823,28,0.55 [0.26-1.18],0.123632333042399
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",11821,32,0.55 [0.27-1.12],0.0976279102762978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9106,72,0.82 [0.53-1.29],0.3901871889376143
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9085,51,0.65 [0.38-1.13],0.1252707941840293
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9099,65,1.33 [0.88-2.01],0.1788820813292293
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Irregular menses,11822,89,1.26 [0.88-1.81],0.2052511318146279
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9226,192,0.93 [0.71-1.22],0.5968347426699012
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9121,87,0.75 [0.49-1.13],0.1703260920689677
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",11824,39,1.24 [0.72-2.12],0.4416286826699978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9145,111,0.81 [0.56-1.16],0.2430264377424562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9083,49,1.34 [0.84-2.14],0.2160856080867494
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9655,621,0.83 [0.71-0.97],0.016717668700112
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22094,85,1.04 [0.70-1.55],0.8297192087226736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19262,651,1.01 [0.87-1.17],0.8983931151308348
